Cardiac care has experienced a remarkable transformation spanning the last five decades, evolving from rudimentary procedures to sophisticated, image-guided interventions that prioritize patient-specific treatment. This journey reflects the broader evolution of medical science as it steadily progresses toward more targeted and effective therapies for heart conditions.
India's Pronounced Evolution in Heart Care
In India, this transformation has been particularly significant. The nation faces one of the world's highest burdens of cardiovascular disease while simultaneously emerging as a global hub for medical technology innovation. This dual challenge has accelerated advancements in cardiac treatment methodologies and device development.
PRISM-PCI Conclave 2026: A Platform for Reflection
This transformation formed the central narrative of the PRISM-PCI Conclave 2026, hosted by Meril Life Sciences at its academy in Vapi from January 16 to 18. The event gathered approximately 300 interventional cardiologists from India and international locations to examine how angioplasty has evolved from a relatively straightforward procedure to an increasingly complex intervention, and how innovation continues to influence patient outcomes.
PRISM, which stands for Precision Revascularization using Innovation-Guided Strategy for management of Complex PCI, represents a changing reality in cardiac care. Contemporary patients frequently present with multi-vessel disease, significant calcification, heart failure, or require intervention at younger ages than in previous decades. Managing such complexity demands more than surgical skill alone—it requires precise imaging, thorough physiological assessment, advanced medical devices, and carefully-planned hybrid strategies.
India's Shift from Consumer to Contributor
During a keynote address on the evolution of PCI in India, Dr. Ashok Seth, Chairman of Fortis Escorts Heart Institute in New Delhi, observed, "India has transitioned from being a consumer of global innovation to becoming a contributor. The past few decades have witnessed remarkable progress—not only in the number of patients treated but in the quality, complexity, and care that makes technological advances more accessible and affordable for patient outcomes. These technology innovations are receiving global recognition."
International Perspectives on Precision Care
International perspectives reinforced this viewpoint. Dr. Samin Sharma, Director of Interventional Cardiology at the Mount Sinai Health System in New York, emphasized the critical importance of precision in modern medical practice. "The future of angioplasty depends on understanding disease pathology more comprehensively—utilizing imaging and physiology to guide clinical decisions. This approach enhances safety and consistency, especially as cases become increasingly complex worldwide," he explained.
Cardiovascular Disease as National Priority
Sanjeev Bhatt, Senior Vice President at Meril, highlighted the broader implications, stating, "Cardiovascular disease today represents not merely a clinical challenge but a national priority. Precision-led care, supported by robust clinical evidence and integrated technology platforms, is essential for improving outcomes for millions of patients. Equally significant is India's current capability to develop these life-saving technologies at scale."
India's Growing Influence in Cardiac Innovation
A recurring theme throughout the conclave sessions was India's expanding role in global cardiac innovation. Over the past decade, domestically developed technologies—including coronary stents, imaging-guided solutions, and transcatheter heart valves—have significantly expanded access to modern cardiac care both within India and internationally. This shift has reduced dependence on imported medical devices while empowering Indian clinicians with tools that meet global standards.
Beyond Technology: The Prevention Imperative
Beyond technological and procedural advancements, the PRISM conclave addressed prevention—a crucial concern as cardiovascular disease increasingly affects younger populations. Experts emphasized that while advanced interventions save lives, long-term impact will depend on early detection, lifestyle modification, and enhanced public awareness initiatives.
Conclusion: A Transformative Healthcare Shift
As the conclave concluded, PRISM represented more than a scientific gathering. It reflected a broader shift in global healthcare dynamics—where India is not only treating one of the world's largest cardiac patient populations but also helping define the future of heart care through innovation, research, and precision-driven solutions.
About Meril Life Sciences
Meril is a global medical device company headquartered in India, dedicated to advancing healthcare through innovation. With a strong emphasis on research and development, Meril delivers cutting-edge medical technology solutions across more than 150 countries and maintains a robust presence through subsidiaries in the United States, Brazil, Europe, Asia, Africa, and Australia. Through strategic partnerships, precision technology development, and adherence to international quality standards, Meril contributes to reshaping the future of healthcare worldwide.
